PierianDx Announces Two New Board Members; Bryan Carey And Frederick Hessler Bring Vast Healthcare Experience
ST LOUIS--(BUSINESS WIRE)--PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced that Bryan J. Carey and Frederick A. Hessler have been appointed to the company’s Board of Directors.
Carey, a seasoned healthcare operating executive with significant experience in private equity, currently serves as the executive vice president, CFO and director of Sunspire Health, a network of recovery centers throughout the country. Prior to joining Sunspire, Carey served as the President and CFO of 21st Century Oncology, Managing Director of Vestar Capital Partners, and CFO and Managing Director, Europe, of Aearo Corporation. During his career, Carey completed many significant acquisitions and managed a range of successful portfolio companies in healthcare.
Carey, a seasoned healthcare operating executive with significant experience in private equity, currently serves as the executive vice president, CFO and director of Sunspire Health, a network of recovery centers throughout the country. Prior to joining Sunspire, Carey served as the President and CFO of 21st Century Oncology, Managing Director of Vestar Capital Partners, and CFO and Managing Director, Europe, of Aearo Corporation. During his career, Carey completed many significant acquisitions and managed a range of successful portfolio companies in healthcare.